Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) — Stock Score Summary

Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) has a MoatMap StockRank of 99/100 based on Quality (67/100), Value (81/100), and Momentum (60/100) factor scores. The current signal is STRONG BUY.

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Key Financial Metrics

Price$7.23
Market Cap$80M
P/E (TTM)16.69
Price/Book0.75
Return on Equity9.7%
Return on Invested Capital4.6%
Debt/Equity45.70
Gross Margin66.1%
Operating Margin16.2%
Revenue Growth30.6%
Dividend Yield6.0%
Free Cash Flow$19K

Ahn-Gook Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Ahn-Gook Pharmaceutical Co., Ltd.’s (001540.KQ) StockRank?
MoatMap’s StockRank for Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) is 99/100, with a Strong Buy signal. It is a composite of Quality (67), Value (81), and Momentum (60) factor ranks across MoatMap’s 19,000+ stock universe.
Does Ahn-Gook Pharmaceutical Co., Ltd. have an economic moat?
Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ahn-Gook Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ahn-Gook Pharmaceutical Co., Ltd. in?
Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).